THE DEAL, AT A GLANCE
From the announcementMeduloc
01Who is involvedBacked by CEO, President Sarah Sachinis, Life Sciences Greenhouse Investments (LSGI), Broad Street AngelsFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗02What happenedMeduloc raised $4M Series B, announced 2026-08-06From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗03Why it mattersMeduloc is using its $4 million Series B to move from regulatory clearance toward launch of an orthopedic fracture fixation platform.From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
Meduloc · Financing Record
Explore source-linked visual explanations for Meduloc. Unsupported claims are withheld while source review continues.
Record 9706 · Recorded date: 2026-08-06
Explore company records →